H3396

Information for H3396

Description

H3396 is a breast cancer cell line.

Source BRENDA Tissue Ontology (BTO)

ReMap Statistics

Datasets
8
Transcriptional Factors
4
Peaks
41,185
Non-redundant peaks
35,899

Description

Cell_name
H3396
Category
Cancer cell line
Disease
NCIt; C4872; Breast carcinoma
Sex_gender_of_cell
Female

External IDs

Cellosaurus
CVCL_D348
Experimental Factor
BRENDA Tissue
Wiki
H3396
ATCC
H3396
Synonyms
3396

External links
All peaks H3396
Download BED file
Non redundant H3396
Download BED file
CRMs H3396
Download BED file
DOWNLOAD All ReMap
Go to catalogue

Datasets Table for H3396

Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks
H3396 E2 CARM1 GEO Homo sapiens GSE32349 Download (19)
H3396 E2 CREBBP M742 GEO Homo sapiens GSE32349 Download (2,833)
H3396 E2 CREBBP M768 GEO Homo sapiens GSE32349 Download (19,221)
H3396 ETOH CREBBP M768 GEO Homo sapiens GSE32349 Download (8,307)
H3396 CREBBP GEO Homo sapiens GSE32349 Download (2,860)
H3396 E2 ESR1 GEO Homo sapiens GSE32349 Download (3,775)
H3396 ETOH ESR1 GEO Homo sapiens GSE32349 Download (1,375)
H3396 E2 NCOA3 GEO Homo sapiens GSE32349 Download (2,795)
Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.